Picolinamide is found to be a strong inhibitor of poly (ADP-ribose) synthetase of nuclei from rat pancreatic islet cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 90 | |
50 mg | In stock | $ 171 | |
100 mg | In stock | $ 214 | |
250 mg | In stock | $ 505 | |
500 mg | In stock | $ 782 |
Description | Picolinamide is found to be a strong inhibitor of poly (ADP-ribose) synthetase of nuclei from rat pancreatic islet cells. |
Targets&IC50 | PARP:95 μM |
In vitro | In AR-HEK293 cells stably expressing full-length hAR, ODM-201 inhibits human AR (hAR) with IC50 of 26 nM. ODM-201 inhibits VCaP cell proliferation with IC50 of 230 nM, while has no effect on the viability of AR-negative cell lines tested, DU-145 prostate cancer cells and H1581 lung cancer cells. |
In vivo | Overnight treatment of rats with picolinamide, administered as a single injection (4 mmol/kg), inhibits Na+/phosphate cotransport by isolated renal brush border membrane vesicles. There is only a small increase (1.5-fold) in renal cortical NAD content after picolinamide treatment. |
Synonyms | 2-Pyridinecarboxamide, Picolinoylamide, 2-Carbamoylpyridine, 2-Picolinamide |
CAS No. | 1452-77-3 |
Chemical Formula | C6H6N2O |
Molecular Weight | 122.127 |
Solubility | DMSO: 23 mg/mL (188.3 mM) Ethanol: 23 mg/mL (188.3 mM); H2O: 22 mg/mL (180.2 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom